Amarin | AMRN - Trade Creditors

Stock Price
15.69
Daily Change
0.27 1.75%
Monthly
-0.44%
Yearly
81.30%
Q1 Forecast
14.88

Amarin reported $36.71M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alnylam Pharmaceuticals USD 115.72M 1.87M Dec/2025
Amarin USD 36.71M 8M Sep/2025
AstraZeneca USD 25.28B 252M Dec/2025
BioCryst Pharmaceuticals USD 15.83M 10.26M Dec/2025
DBV Technologies USD 39.82M 972K Sep/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Novartis USD 4.56B 49M Sep/2025